Cite

    Nagai, T. et al. (2023). Identification of the α2 chain of interleukin‐13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient‐derived xenograft models. Cancer reports. 6 (2), p. n/a. [Online].